Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

NSE/NEULANDLAB stock hub

NSE/NEULANDLAB has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

NSE/NEULANDLABis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

227B

National Stock Exchange of India

Market data

Live price

Current market quote for this ticker.

Current price

NSE/NEULANDLAB

In the news

Latest news · NSE/NEULANDLAB

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E58.1

P25 24.9P50 32.4P75 45.7

Trailing P/E126.7

P25 24.8P50 35.9P75 56.9

ROEn/a

P25 6.3P50 13.6P75 18.1

ROIC10.5

P25 4.1P50 10.3P75 17.9

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All NSE/NEULANDLAB market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

192

Groups with data

Currency

INR

Showing 192 of 192 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	India
Country code	IN
Employees	1,794
Employees Change	151%
Employees Change Percent	9.19
Enterprise value	INR 228B
Exchange	National Stock Exchange of India
Financial currency	INR
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Isin	INE794A01010
Last refreshed	2026-05-10
Market cap	INR 227B
Price	INR 17,750
Price currency	INR
Rev Per Employee	8,779,794.31x
Sector	Healthcare
Sic	2833
Symbol	nse/NEULANDLAB
Website	https://www.neulandlabs.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	0.79%
EV Earnings	127.26x
EV/EBIT	94.2x
EV/EBITDA	73.74x
EV/Sales	14.47x
Forward P/E	58.1x
P/B ratio	14.01x
P/E ratio	126.73x
P/S ratio	14.41x
PE Ratio10 Y	31.18x
PE Ratio3 Y	47.93x
PE Ratio5 Y	39.61x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	15.36%
EBITDA Margin	19.31%
Gross margin	49.33%
Gross Profit	INR 7.8B
Gross Profit Growth	0.26%
Gross Profit Growth Q	1.97%
Gross Profit Growth3 Y	16.97%
Gross Profit Growth5 Y	16.92%
Net Income	INR 1.8B
Net Income Growth	-40.26%
Net Income Growth Q	-60.06%
Net Income Growth Years	0%
Net Income Growth3 Y	21.14%
Net Income Growth5 Y	27.08%
Pretax Margin	15.29%
Profit Margin	11.37%
Profit Per Employee	INR 998,504
Profitable Years	15
Roa5y	8.51
Roe5y	16.27
ROIC	10.49
Roic5y	14.48

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	37.78%
Cagr15y	40.82%
Cagr1y	46.9%
Cagr3y	105.56%
Cagr5y	46.3%
Div CAGR10	19.62%
Div CAGR3	6.27%
Div CAGR5	19.14%
EPS Growth	-40.26
EPS Growth Q	-60.07
EPS Growth Years	0
EPS Growth3 Y	21.15
EPS Growth5 Y	27.09
Revenue Growth	2.71x
Revenue Growth Q	10.47x
Revenue Growth Quarters	2x
Revenue Growth Years	0x
Revenue Growth3 Y	14.82x
Revenue Growth5 Y	12.22x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Cash	INR 1.7B
Debt	INR 2.6B
Debt EBITDA	INR 0.86
Debt Equity	INR 0.16
Equity	INR 16.2B
Interest Coverage	14.6
Net Cash	INR -958.1M
Net Cash By Market Cap	INR -0.42
Net Debt EBITDA	INR 0.31
Net Debt Equity	INR 0.06
Tangible Book Value	INR 13.3B
Tangible Book Value Per Share	INR 1,038
WACC	2.51

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	0%
Dividend Growth	-14.29%
Dividend Growth Years	0%
Dividend per share	INR 12
Dividend Years	7
Dividend Yield	0.07%
Ex Div Date	2025-07-18
Last Dividend	INR 12
Payout Frequency	Annual

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	2,364.76%
1Y total return	46.86%
200-day SMA	14,640.1
3Y total return	768.99%
50-day SMA	13,741.6
50-day SMA vs 200-day SMA	50under200
5Y total return	570.12%
All Time High	19,747
All Time High Change	-10.11%
All Time High Date	2025-11-10
All Time Low	63.9
All Time Low Change	27,677.78%
All Time Low Date	2012-05-03
ATR	630.4
Beta	-0.32
Ch YTD	16.97
High	17,765
High52	19,747
High52 Date	2025-11-10
High52ch	-10.11%
Low	17,222
Low52	10,578
Low52 Date	2025-05-16
Low52ch	67.8%
Ma50ch	29.17%
Price vs 200-day SMA	21.24%
RSI	77.92
RSI Monthly	65.3
RSI Weekly	65.77
Sharpe ratio	1x
Sortino ratio	1.93
Total Return	0.08%
Tr YTD	16.97
Tr15y	16,878.89%
Tr1m	34.72%
Tr1w	10.08%
Tr3m	36.22%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	INR 2.4B
Operating Income Growth	-23.04
Operating Income Growth Q	-24.3
Operating Income Growth3 Y	18.78
Operating Income Growth5 Y	15.4
Operating margin	15.36

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	7,235,008%
Shares Insiders	11.52%
Shares Institutions	24.97%
Shares Qo Q	0.01%
Shares Yo Y	-0%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	51,634.55x
Bv Per Share	1,262.8
Ch10y	2,310.5
Ch15y	13,372.5
Ch1m	34.72
Ch1w	10.08
Ch1y	46.74
Ch3m	36.22
Ch3y	763.8
Ch5y	562.3
Ch6m	-0.49
Change	2.69%
Change From Open	2.68
Close	17,285
Days Gap	0.01
Depreciation Amortization	622,144,750
Dollar Volume	1,594,234,000
Earnings Date	2026-05-12
EBIT	INR 2.4B
EBITDA	INR 3B
EPS	INR 140
F Score	1
Fiscal Year End	March
Founded	1,984
Graham Number	1998.08429
Graham Upside	-88.74
Income Tax	INR 616.5M
Is Primary Listing	0
Last Earnings Date	2026-02-09
Last Report Date	2025-12-31
Lynch Fair Value	INR 3,502
Lynch Upside	-80.27
Ma150	14,824.7
Ma150ch	19.73%
Ma20	15,360.2
Ma20ch	15.56%
Next Earnings Date	2026-05-12
Open	17,286
Payment Date	2025-08-29
Position In Range	97.24
Price Date	2026-05-08
Price EBITDA	INR 74.62
Ptbv Ratio	17.04
Relative Volume	1.82x
Revenue	15,750,951,000x
Tax By Revenue	3.91x
Tax Rate	25.6%
Tr6m	-0.49%
Volume	89,816

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

NSE/NEULANDLAB dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+0.1%

$12.0 annual per share

Payout ratio

n/a

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+19.1%

0 consecutive years of growth

Total shareholder yield

+0.1%

Next ex-dividend date: 2025-07-18

Performance

NSE/NEULANDLAB stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns NSE/NEULANDLAB?

Insider, institutional, and short-interest positioning.

Institutional ownership

+25.0%

Share of float held by funds and institutions

Insider ownership

+11.5%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

-0.0%

Negative means the company is buying back shares.

Technical

NSE/NEULANDLAB momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

77.9

Above 70: short-term overbought

Price vs 200-day MA

+21.2%

50/200-day relationship not available

Beta (5Y)

-0.32

Less volatile than the market

Sharpe ratio

1.00

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About NSE/NEULANDLAB

Hub-level FAQ points readers to the deeper analysis pages.

What is the current nse/NEULANDLAB stock rating?

nse/NEULANDLAB is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full nse/NEULANDLAB analysis?

The full report lives at /stocks/nse/NEULANDLAB/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for nse/NEULANDLAB?

The latest report frames nse/NEULANDLAB around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the nse/NEULANDLAB page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.